Blepharospasm Completed Phase 2 Trials for Mexiletine (DB00379)

Also known as: Spasm eyelid / Eyelid twitching

IndicationStatusPhase
DBCOND0001075 (Blepharospasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001784Mexiletine for the Treatment of Focal DystoniaTreatment